TrialJournal of clinical psychopharmacology

Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users.

Ishani Landry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.